Pharmacists Reducing Stigma & Buprenorphine Access
- Here's a breakdown of the provided text, focusing on the key takeaways from the interview with Caroline Pearson:
- Main Topic: improving treatment retention for Opioid Use Disorder (OUD).
- * clinical Significance of 13 Days: An extra 13 days of treatment retention is clinically meaningful. Experts emphasize that any lapse in treatment increases overdose risk, especially immediately...
Here’s a breakdown of the provided text, focusing on the key takeaways from the interview with Caroline Pearson:
Main Topic: improving treatment retention for Opioid Use Disorder (OUD).
Key Points:
* clinical Significance of 13 Days: An extra 13 days of treatment retention is clinically meaningful. Experts emphasize that any lapse in treatment increases overdose risk, especially immediately after starting treatment. 13 days of improvement is considered significant, exceeding the results of many other interventions. Though, it’s not considered “good enough” given current low retention rates.
* Long-Term Focus: The OUD journey is long-term, and the goal is to find more effective, longer-lasting treatment options.
* Promising Innovations: Virtual care, specifically digital support services, are seen as a valuable addition to treatment options. Peer support and group conversations are especially helpful for some individuals.
* Individualized Approach: People benefit from a variety of treatment approaches, highlighting the need for personalized care.
In essence, the interview highlights the importance of even small gains in treatment retention for OUD, while also emphasizing the need for continued innovation and a focus on long-term recovery.